FDAQRC experienced great success in 2023. Throughout the year, we invested in our staff, increased total project resources, and connected with industry professionals at various conferences and events.
In 2023; FDAQRC completed 501 projects, with Inspection Readiness being our most requested service of the year. Our global consultant network increased to over 450 active consultants. Our Employees attended several conferences, including the Drug Information Association 2023 Global Annual Meeting (DIA), the Society of Quality Assurance 2023 Annual Conference (SQA), the International Research Quality Association 2023 conference (RQA), and the 2nd Annual GCP Inspection Readiness Conference.
Company President, Chris Rush said it best, “We have laid the groundwork with an amazing team and 2024 has the potential to be our best year yet.” We are looking forward to all the great things FDAQRC has planned in 2024.